Insider Trading History of Traverso Kenneth M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Traverso Kenneth M since 2005. The trader's CIK number is 1208700. At the time of the last reporting, Traverso Kenneth M was the VP Marketing and Sal of Natus Medical Inc. (stock ticker symbol NTUS). Also see all insider trading activities at Natus Medical Inc.



Yearly summary of insider trading at Natus Medical Inc (BABY) by Traverso Kenneth M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 BABY 0 $0 7,459 $250,324 7,459 $125,162
2015 BABY 0 $0 101,713 $4,117,749 78,541 $921,994
2014 BABY 0 $0 67,459 $1,979,566 50,000 $723,700
2013 BABY 0 $0 65,043 $1,052,101 50,000 $225,499
2012 BABY 0 $0 109,867 $1,261,878 116,157 $406,933
2011 BABY 0 $0 50,444 $807,594 45,000 $191,655
2010 BABY 0 $0 103,209 $1,741,897 100,000 $624,999
2009 BABY 0 $0 41,724 $469,729 0 $0
2008 BABY 0 $0 60,617 $1,458,973 0 $0
2005 BABY 0 $0 25,450 $422,843 0 $0


Insider trading of Natus Medical Inc (BABY) by Traverso Kenneth M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-04-22 BABY Sale 7,459 33.56 250,324
2016-04-22 BABY Option Ex 7,459 16.78 125,162
2015-07-24 BABY Option Ex 16,000 16.78 268,480
2015-07-24 BABY Sale 16,000 45.54 728,640
2015-07-28 BABY Option Ex 2,541 16.78 42,637
2015-07-28 BABY Sale 2,541 45.77 116,301
2015-05-26 BABY Option Ex 25,939 10.38 269,246
2015-05-26 BABY Sale 25,939 36.19 938,732
2015-04-28 BABY Sale 57,233 40.78 2,334,076
2015-04-28 BABY Option Ex 34,061 10.03 341,631
2014-10-24 BABY Option Ex 30,000 10.73 321,900
2014-10-24 BABY Sale 30,000 33.33 999,900
2014-03-06 BABY Sale 8,932 27.60 246,523
2014-02-20 BABY Option Ex 20,000 20.09 401,800
2014-02-20 BABY Sale 28,527 25.70 733,143
2013-10-29 BABY Sale 5,000 19.72 98,600
2013-10-28 BABY Sale 20,000 19.50 390,000
2013-10-28 BABY Option Ex 20,000 4.51 90,200
2013-09-12 BABY Sale 2,800 13.91 38,948
2013-09-10 BABY Sale 1,425 13.85 19,736
2013-08-19 BABY Sale 5,818 12.78 74,354
2013-06-05 BABY Option Ex 22,682 4.51 102,295
2013-06-05 BABY Sale 22,682 14.30 324,352
2013-06-03 BABY Sale 7,318 14.50 106,111
2013-06-03 BABY Option Ex 7,318 4.51 33,004
2012-11-30 BABY Option Ex 26,157 3.50 91,549
2012-11-30 BABY Sale 26,157 11.42 298,712
2012-11-09 BABY Option Ex 76,042 3.45 262,344
2012-11-09 BABY Sale 49,885 11.19 558,213
2012-08-15 BABY Sale 5,446 11.55 62,901
2012-05-03 BABY Option Ex 13,958 3.80 53,040
2012-05-03 BABY Sale 28,379 12.05 342,052
2011-08-16 BABY Sale 899 10.25 9,214
2011-08-17 BABY Sale 3,602 10.21 36,776
2011-08-02 BABY Sale 943 11.24 10,599
2011-05-03 BABY Option Ex 30,000 3.80 114,000
2011-05-03 BABY Sale 30,000 17.26 517,800
2011-03-15 BABY Sale 15,000 15.55 233,205
2011-03-15 BABY Option Ex 15,000 5.18 77,655
2010-08-17 BABY Sale 1,814 12.91 23,418
2010-08-03 BABY Sale 1,395 14.33 19,990
2010-06-02 BABY Option Ex 16,700 6.25 104,375
2010-06-02 BABY Sale 16,700 16.75 279,725
2010-05-28 BABY Sale 9,072 16.59 150,504
2010-05-27 BABY Sale 42,539 16.48 701,042
2010-05-28 BABY Option Ex 9,072 6.25 56,700
2010-05-27 BABY Option Ex 42,539 6.25 265,868
2010-05-17 BABY Option Ex 25,000 6.25 156,250
2010-05-18 BABY Option Ex 6,689 6.25 41,806
2010-05-17 BABY Sale 25,000 17.87 446,750
2010-05-18 BABY Sale 6,689 18.01 120,468
2009-08-05 BABY Sale 2,162 14.20 30,702
2009-08-05 BABY Sale 2,162 14.20 30,702
2009-06-03 BABY Sale 25,000 11.44 285,975
2009-05-29 BABY Sale 12,400 9.87 122,350
2008-09-09 BABY Sale 18,800 24.26 456,088
2008-09-10 BABY Sale 31,200 23.98 748,144
2008-09-11 BABY Sale 9,751 23.98 233,828
2008-08-04 BABY Sale 866 24.15 20,913
2005-11-16 BABY Sale 24,450 16.60 405,943
2005-11-11 BABY Sale 1,000 16.90 16,900

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Traverso Kenneth M (VP Marketing and Sal of Natus Medical Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.